Greenlight Capital’s Gain Therapeutics GANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $1.92M | Hold |
588,410
| – | – | 0.09% | 33 |
|
|
2023
Q3 | $1.93M | Buy |
588,410
+41,850
| +8% | +$137K | 0.11% | 30 |
|
|
2023
Q2 | $2.45M | Hold |
546,560
| – | – | 0.11% | 30 |
|
|
2023
Q1 | $2.63M | Hold |
546,560
| – | – | 0.14% | 29 |
|
|
2022
Q4 | $1.71M | Hold |
546,560
| – | – | 0.12% | 31 |
|
|
2022
Q3 | $1.78M | Hold |
546,560
| – | – | 0.13% | 31 |
|
|
2022
Q2 | $1.97M | Hold |
546,560
| – | – | 0.15% | 35 |
|
|
2022
Q1 | $2.24M | Hold |
546,560
| – | – | 0.14% | 39 |
|
|
2021
Q4 | $2.97M | Hold |
546,560
| – | – | 0.17% | 39 |
|
|
2021
Q3 | $4.07M | Hold |
546,560
| – | – | 0.27% | 32 |
|
|
2021
Q2 | $5.47M | Hold |
546,560
| – | – | 0.34% | 34 |
|
|
2021
Q1 | $8.16M | Buy |
+546,560
| New | +$8.16M | 0.57% | 28 |
|